• Explore /
  • Poster
  • / Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A retrospective study.

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A retrospective study.

Abstract Poster

Authors

null

Kosuke Hamada

Osaka City University Graduate School of Medicine, Osaka, Japan

Kosuke Hamada , Taro Iguchi , Satoshi Tamada , Minoru Kato , Takeshi Yamasaki , Yuji Takeyama , Yasuomi Shimizu , Sayaka Yasuda , Tatsuya Nakatani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 293)

DOI

10.1200/JCO.2019.37.7_suppl.293

Abstract #

293

Poster Bd #

D1

Abstract Disclosures

Similar Posters

First Author: Hiroji Uemura

First Author: Ugo De Giorgi

First Author: Taro Iguchi

First Author: Koji Hatano